Health Care Utilization and Costs Among Patients Treated for Bipolar Disorder in an Insured Population
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The study examined health care utilization and costs among patients treated for bipolar-spectrum disorders in an insured population. METHODS: Computerized data on prescriptions and on outpatient and inpatient diagnoses from a large health plan were used to identify patients treated for cyclothymia, bipolar disorder, or schizoaffective disorder. Three age- and sex-matched comparison groups consisting of general medical outpatients, patients treated for depression, and patients treated for diabetes were selected from health plan members. Utilization and cost of health services for the four groups over a six-month period were assessed using computerized accounting records. RESULTS: Total mean+/-SD costs for patients in the bipolar disorder group ($3,416+/-$6,862) were significantly higher than those in any of the comparison groups. Specialty mental health and substance abuse services accounted for 45 percent of total costs in the group with bipolar disorder (mean+/-SD=$1, 566+/-$3,243), compared with 10 percent in the group with depression. Among patients treated for bipolar disorder, 5 percent of patients accounted for approximately 40 percent of costs for specialty mental health and substance abuse services, 90 percent of inpatient costs for specialty mental health and substance abuse services, and 95 percent of out-of-pocket costs for inpatient care. In the bipolar disorder group, parity coverage of inpatient mental health and substance abuse services would increase overall health care costs by 6 percent. CONCLUSIONS: Health care costs for patients with bipolar disorder exceed those for patients treated for depression or diabetes, and specialty mental health and substance abuse treatment costs account for this difference. Costs to the insurer and costs borne by patients are accounted for by a small proportion of patients. Elimination of discriminatory mental health coverage would have a small effect on overall health care costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Priester, M. A., Browne, T., Iachini, A., Clone, S., DeHart, D., & Seay, K. D. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.09.006 · Cited by 561
“…utilization and costs among persons with COD, other studies suggest that this population has markedly lower treatment entry and utilization than those with only substance use or only mental disorders (Curran et al., 2003; Simon & Unutzer, 1999; Verduin, Carter, Brady, Myrick, & Timmerman, 2005).”
BackgroundSachs, G. S., Thase, M. E., Otto, M. W., Bauer, M., Miklowitz, D., Wisniewski, S. R., Lavori, P., Lebowitz, B., Rudorfer, M., Frank, E., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00165-3 · Cited by 533
The Increasing Medical Burden in Bipolar Disorder
Kupfer, D. J. (2005) · JAMA · doi:10.1001/jama.293.20.2528 · Cited by 489
Social and economic burden of mood disorders
Simon, G. E. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00420-7 · Cited by 429
Self-citationSchoenbaum, M., Unützer, J., Sherbourne, C., Duan, N., Rubenstein, L. V., Miranda, J., Meredith, L. S., Carney, M. F., & Wells, K. (2001) · JAMA · doi:10.1001/jama.286.11.1325 · Cited by 333
Self-citation(2011) · PubMed · Cited by 321
Haloperidol alone or in combination for acute mania
Cipriani, A., Rendell, J. M., & Geddes, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004362.pub2 · Cited by 285
Dean, B. B., Gerner, D., & Gerner, R. H. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125002801 · Cited by 283
The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
Begley, C. E., Annegers, J. F., Swann, A. C., Lewis, C., Coan, S., Schnapp, W. B., & Bryant-Comstock, L. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119050-00004 · Cited by 265
“Direct Medical Care Cost Several studies have shown that persons with mental illness, and bipolar disorder in particular, require greater than average medical care in addition to mental health services.[17,29,30] To obtain estimates of this cost,medical care claimsof patients diagnosed with bipolar disorder (n = 2883)…”
Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S. V., MacQueen, G., McIntyre, R. S., Sharma, V., Beaulieu, S., & for CANMAT guidelines group (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00432.x · Cited by 264
Long-term Effectiveness and Cost of a Systematic Care Program for Bipolar Disorder
Simon, G. E., Ludman, E. J., Bauer, M. S., Unützer, J., & Operskalski, B. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.500 · Cited by 263
Self-citationSmulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.003 · Cited by 192
Rationale and First Results of Developing At-Risk (Prodromal) Criteria for Bipolar Disorder
Bechdolf, A., Ratheesh, A., J. Wood, S., Tecic, T., Conus, P., Nelson, B., M. Cotton, S., M. Chanen, A., P. Amminger, G., Ruhrmann, S., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316226 · Cited by 82
McIntyre, R. S., Rosenbluth, M., Ramasubbu, R., Bond, D. J., Taylor, V. H., Beaulieu, S., & Schaffer, A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400209 · Cited by 70
Ogawa, Y., Tajika, A., Takeshima, N., Hayasaka, Y., & Furukawa, T. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0197-8 · Cited by 66
“It also carries with it significant increases in morbidity, socio-economic costs and risks of suicide [3].”
BackgroundFRIEDLANDER, A. H., FRIEDLANDER, I. K., & MARDER, S. R. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0362 · Cited by 41
Mezuk, B., Morden, N. E., Ganoczy, D., Post, E. P., & Kilbourne, A. M. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181bf9ebd · Cited by 36
The burden of general medical conditions in patients with bipolar disorder
Kilbourne, A. M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0069-5 · Cited by 34
The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study
Hong, J., Reed, C., Novick, D., Haro, J. M., Windmeijer, F., & Knapp, M. (2010) · PharmacoEconomics · doi:10.2165/11535200-000000000-00000 · Cited by 26
Use of treatment services in a comparative effectiveness study of bipolar disorder
Sylvia, L. G., Iosifescu, D., Friedman, E. S., Bernstein, E. E., Bowden, C. L., Ketter, T. A., Reilly-Harrington, N. A., Leon, A. C., Calabrese, J. R., Ostacher, M. J., et al. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200479 · Cited by 3
Metadata
- Authors
- Simon, G. E., & Unützer, J.
- Venue
- Psychiatric Services
- Published
- 1999-10
- Volume
- 50
- Issue
- 10
- Pages
- 1303-1308
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2163776898
- Cited by
- 145
- References
- 0
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.